Abstract

Neisseria meningitidis is a commensal bacterium of the human nasopharynx. In rare cases, it penetrates the mucosa, entering the blood stream and causing various forms of disease. Meningococcal conjugate vaccines can prevent invasive disease not only by direct effect in vaccinated individuals but also by herd protection, preventing acquisition of carriage, which interrupts transmission and leads to protection of unvaccinated persons. In 2010 in Salvador, Brazil, an outbreak of group C meningococcal disease led to a mass meningococcal serogroup C conjugate vaccination drive, targeting those <5 and 10–24 years of age. The present study aimed to estimate the prevalence of and identify factors associated with N. meningitidis carriage among adolescents from Salvador, Brazil, in the post-vaccination period. In spring 2014, we performed a cross-sectional study involving 1,200 public school students aged 11–19 years old. Oropharyngeal swabs were collected to identify N. meningitidis. Of the 59 colonized participants, 36 (61.0%) carried non-groupable N. meningitidis, while genogroup B (11.9%), Y (8.5%), E (6.8%), Z (5.1%), C (3.4%), and W (3.4%) were also detected. The overall prevalence of N. meningitidis carriage was 4.9% (95% confidence interval [CI], 3.6–6.1%); the prevalence of N. meningitidis genogroup C was 0.17% (95% CI, 0.0–0.40%). There was no difference by age. Factors associated with carriage were having only one, shared, bedroom in the household (PR, 2.02; 95% CI, 0.99–4.12, p = 0.05); the mother being the only smoker in the home (PR, 2.48; 95% CI, 1.16–5.29; p = 0.01); and going to pubs/parties more than 5 times/month (PR, 2.61; 95% CI, 1.38–4.92; p = 0.02). Our findings show that the N. meningitidis carriage rate in adolescents from Salvador, Bahia, is low and is potentially influenced by the low prevalence of N. meningitidis genogroup C. However, continued surveillance is important to identify changes in the dynamics of N. meningitidis, including the emergence of diseases due to a non-C serogroup.

Highlights

  • Neisseria meningitidis is commonly carried as part of the commensal microbiota in the upper respiratory tract of humans

  • The results of this study showed that the overall prevalence of N. meningitidis carriage after the mass meningococcal serogroup C conjugate (MCC) vaccination campaign was 4.9%, while carriage of N. meningitidis group C was 0.17%

  • The overall prevalence for adolescents in Salvador was lower than the prevalence (9.9%) observed in a similar study performed in Campinas, Brazil, after introducing the MCC vaccine among children

Read more

Summary

Introduction

Neisseria meningitidis is commonly carried as part of the commensal microbiota in the upper respiratory tract of humans. Occasionally the bacteria invade the bloodstream and causes severe diseases, such as meningitis and sepsis, which can be fatal or produce permanent neurological sequelae in survivors [1]. Most cases are caused by 6 of the 12 recognized capsular groups (A, B, C, W, Y and X), which are defined based on the different immunochemical variants of the polysaccharide capsules produced by the bacteria [3]. The incidence of MD is cyclical in nature and varies geographically and over time [4]. In Latin America, the incidence of MD varies from

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call